diphenhydramine hydrochloride has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HC; Kim, HJ; Lee, PH; Nabeshima, T; Shin, EJ | 1 |
| Chase, TN; Del Dotto, P; Natté, R; van den Munckhof, P; Verhagen Metman, L | 1 |
1 review(s) available for diphenhydramine hydrochloride and Parkinson Disease
| Article | Year |
|---|---|
Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects.
Topics: Animals; Antitussive Agents; Behavior, Animal; Brain Ischemia; Central Nervous System; Dextromethorphan; Humans; Neuroprotective Agents; Parkinson Disease; Seizures; Structure-Activity Relationship; Substance-Related Disorders | 2008 |
1 trial(s) available for diphenhydramine hydrochloride and Parkinson Disease
| Article | Year |
|---|---|
Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Antitussive Agents; Dextromethorphan; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, N-Methyl-D-Aspartate | 1998 |